The end of a 13-year partnership between Under Armour and Stephen Curry has created a rare opportunity for competitors to capture significant market share in the basketball apparel space.
With Curry's brand now independent, major sportswear companies are likely positioning themselves for what could be one of the most valuable athlete partnerships in the industry.
Sporting goods retailers stand to benefit as increased competition among brands drives marketing spend and promotional activity to win over consumers.
This basket's total market capitalisation is $183.68B and is heavily anchored by a few large-cap constituents. That concentration generally leads to a more stable, lower-risk profile versus small-cap‑led baskets.
NKE: $97.61B
LULU: $20.12B
DECK: $12.11B
The end of Under Armour's 13-year partnership with Stephen Curry has created a significant disruption in the athletic apparel industry. This event-driven opportunity focuses on companies positioned to capture market share or potentially collaborate with the now-independent Curry Brand, offering exposure to tactical shifts in the consumer discretionary sector.
This collection includes established sportswear leaders, emerging challengers, and key sporting goods retailers. As an event-driven theme, it may experience higher volatility but also presents growth potential as brands compete for the market share previously held by Under Armour's Curry line.
These companies were handpicked by professional analysts based on their strategic positioning within the athletic apparel ecosystem. Each stock represents a different angle on capitalising from this market disruption, from direct competitors like Nike to specialty retailers who distribute these products.
Under Armour and Stephen Curry have ended their long-standing partnership, creating a major shift in the athletic apparel landscape. This development presents a significant opportunity for competing sportswear brands to gain market share and potentially partner with the globally recognized Curry Brand.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Published on November 14
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+4
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+94.74%
On average, analysts expect assets in this group to grow 94.74% over the next year.
7 of 14 assets in this group are rated Buy by professional analysts.
